Alcohol and coronary heart disease: Consistent relationship and public health implications

Clinica Chimica Acta

Volumn 246, Issue 1-2, 1996, Pages 51-57

  Criqui, Michael H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol; Blood pressure; Coronary heart disease; Lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ALCOHOL CONSUMPTION; BLOOD PRESSURE; CONFERENCE PAPER; DOSE RESPONSE; DRUG ABUSE; HEART ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029864688     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06226-2     Document Type: Conference Paper

References (27)

1. Marmot M, Brunner E. Alcohol and cardiovascular disease: the status of the U-shaped curve. Br Med J 1991;303:565-568.
2. St. Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979;1:1017-1020.
3. Renaud SC, de Lorgeril M. Wine, alcohol, platelets, and the French Paradox for coronary heart disease. Lancet 1992;379:1523-1526.
4. Artaud-Wild SM, Connor S, Sexton G, Connor W. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland: a paradox. Circulation 1993;88:2771-2779.
5. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet 1994;344:1719-1723.
6. Boffetta P, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology 1990;1:342-348.
7. Camargo CA, Jr., Gaziano M, Hennekens CH, Manson JE, Stampfer MJ. Prospective study of moderate alcohol consumption and mortality in male physicians. Circulation 1994;90(suppl I):I-341 (abstract).
8. Haskell WL, Camargo C, Williams PT, et al. The effect of cessation and resumption of moderate alcohol intake on serum high density lipoprotein subfractions: a controlled study. N Engl J Med 1984;253:2854-2857.
9. Jacobs DR, Mebane I, Bangdiwala SI, Criqui MH, Tyroler HA. For the Lipid Research Clinics Program. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990;131:32-47.
10. Criqui MH, Cowan LD, Heiss G, Haskell WL, Laskarzewski PM, Chambless LE. Frequency and clustering of non-lipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study. Circulation 1986;73:1-40-1-50.
11. Meade TW, Chakrabarti R, Haines A, North WR, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979;1:153-156.
12. 2) synthesis, platelet aggregation, and platelet thromboxane release. Br Med J 1983;287:1495-1498.
13. Renaud SC, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr 1992;55:1012-1017.
14. Folts JD, Demrow HS, Slane PR. Two glasses of red but not white wine inhibits ex-vivo platelet aggregation and increases bleeding time in human volunteers. J Am Coll Cardiol 1994;23:49A (abstract).
15. Haselager EM, Vreeken J. Rebound thrombocytosis after alcohol abuse: a possible risk factor in pathogenesis of thromboembolic disease. Lancet 1977;1:774-775.
16. Criqui MH. Alcohol and hypertension: new insights from population studies. Eur Heart J 1987;8:19-26.
17. Ettinger PO, Wu CF, De la Cruz C, Weisse AB, Ahmed SS, Regan TJ. Arrhythmias and the 'holiday heart': alcohol associated cardiac rhythm disorders. Am Heart J 1978;95:555-562.
18. Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E. The effect of alcoholism on skeletal and cardiac muscle. N Engl J Med 1989;320:409-415.
19. Criqui MH, Cowan LD, Tyroler HA et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality. Results from the Lipid Research Clinics Follow-up Study. Am J Epidemiol 1987;126:629-637.
20. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biologic pathways for the effect of moderate alcohol consumption on coronary heart disease. Circulation 1992;85:910-915.
21. Suh I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high density lipoprotein cholesterol. Ann Intern Med 1992;116:881-887.
22. Gaziano JM, Buring JE, Breslow JL et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-1834.
23. Criqui MH. Opening remarks for "Prospective effects of moderate consumption of alcohol on the incidence of coronary heart disease". In: Multiple risk factors in cardiovascular disease. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1995, 413-415.
24. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary heart disease in men. Lancet 1991;338:464-468.
25. Jackson R, Scragg R, Beaglehole R. Alcohol consumption and risk of coronary heart disease. Br Med J 1991;303:211-216.
26. Shuckit MA. Alcohol and alcoholism. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, and Fauci AS, eds. Harrison's principles of internal medicine. New York: McGraw-Hill, 1987;2106-2111.
27. McGinnis JM, Foege WH. Actual causes of death in the United States. J Am Med Assoc 1993;270:2207-2212.